Design and Inference for Cancer Biomarker Study with an Outcome and Auxiliary-Dependent Subsampling
In cancer research, it is important to evaluate the performance of a biomarker (e.g., molecular, genetic, or imaging) that correlates patients' prognosis or predicts patients' response to treatment in a large prospective study. Due to overall budget constraint and high cost associated with...
Saved in:
| Published in | Biometrics Vol. 66; no. 2; pp. 502 - 511 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Malden, USA
Blackwell Publishing Inc
01.06.2010
Wiley-Blackwell Blackwell Publishing Ltd |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0006-341X 1541-0420 1541-0420 |
| DOI | 10.1111/j.1541-0420.2009.01280.x |
Cover
| Abstract | In cancer research, it is important to evaluate the performance of a biomarker (e.g., molecular, genetic, or imaging) that correlates patients' prognosis or predicts patients' response to treatment in a large prospective study. Due to overall budget constraint and high cost associated with bioassays, investigators often have to select a subset from all registered patients for biomarker assessment. To detect a potentially moderate association between the biomarker and the outcome, investigators need to decide how to select the subset of a fixed size such that the study efficiency can be enhanced. We show that, instead of drawing a simple random sample from the study cohort, greater efficiency can be achieved by allowing the selection probability to depend on the outcome and an auxiliary variable; we refer to such a sampling scheme as outcome and auxiliary-dependent subsampling (OADS). This article is motivated by the need to analyze data from a lung cancer biomarker study that adopts the OADS design to assess epidermal growth factor receptor (EGFR) mutations as a predictive biomarker for whether a subject responds to a greater extent to EGFR inhibitor drugs. We propose an estimated maximum-likelihood method that accommodates the OADS design and utilizes all observed information, especially those contained in the likelihood score of EGFR mutations (an auxiliary variable of EGFR mutations) that is available to all patients. We derive the asymptotic properties of the proposed estimator and evaluate its finite sample properties via simulation. We illustrate the proposed method with a data example. |
|---|---|
| AbstractList | In cancer research, it is important to evaluate the performance of a biomarker (e.g., molecular, genetic, or imaging) that correlates patients' prognosis or predicts patients' response to treatment in a large prospective study. Due to overall budget constraint and high cost associated with bioassays, investigators often have to select a subset from all registered patients for biomarker assessment. To detect a potentially moderate association between the biomarker and the outcome, investigators need to decide how to select the subset of a fixed size such that the study efficiency can be enhanced. We show that, instead of drawing a simple random sample from the study cohort, greater efficiency can be achieved by allowing the selection probability to depend on the outcome and an auxiliary variable; we refer to such a sampling scheme as outcome and auxiliary-dependent subsampling (OADS). This article is motivated by the need to analyze data from a lung cancer biomarker study that adopts the OADS design to assess epidermal growth factor receptor (EGFR) mutations as a predictive biomarker for whether a subject responds to a greater extent to EGFR inhibitor drugs. We propose an estimated maximum-likelihood method that accommodates the OADS design and utilizes all observed information, especially those contained in the likelihood score of EGFR mutations (an auxiliary variable of EGFR mutations) that is available to all patients. We derive the asymptotic properties of the proposed estimator and evaluate its finite sample properties via simulation. We illustrate the proposed method with a data example. Summary In cancer research, it is important to evaluate the performance of a biomarker (e.g., molecular, genetic, or imaging) that correlates patients' prognosis or predicts patients' response to treatment in a large prospective study. Due to overall budget constraint and high cost associated with bioassays, investigators often have to select a subset from all registered patients for biomarker assessment. To detect a potentially moderate association between the biomarker and the outcome, investigators need to decide how to select the subset of a fixed size such that the study efficiency can be enhanced. We show that, instead of drawing a simple random sample from the study cohort, greater efficiency can be achieved by allowing the selection probability to depend on the outcome and an auxiliary variable; we refer to such a sampling scheme as outcome and auxiliary‐dependent subsampling (OADS). This article is motivated by the need to analyze data from a lung cancer biomarker study that adopts the OADS design to assess epidermal growth factor receptor (EGFR) mutations as a predictive biomarker for whether a subject responds to a greater extent to EGFR inhibitor drugs. We propose an estimated maximum‐likelihood method that accommodates the OADS design and utilizes all observed information, especially those contained in the likelihood score of EGFR mutations (an auxiliary variable of EGFR mutations) that is available to all patients. We derive the asymptotic properties of the proposed estimator and evaluate its finite sample properties via simulation. We illustrate the proposed method with a data example. In cancer research, it is important to evaluate the performance of a biomarker (e.g. molecular, genetic, or imaging) that correlates patients’ prognosis or predicts patients’ response to a treatment in large prospective study. Due to overall budget constraint and high cost associated with bioassays, investigators often have to select a subset from all registered patients for biomarker assessment. To detect a potentially moderate association between the biomarker and the outcome, investigators need to decide how to select the subset of a fixed size such that the study efficiency can be enhanced. We show that, instead of drawing a simple random sample from the study cohort, greater efficiency can be achieved by allowing the selection probability to depend on the outcome and an auxiliary variable; we refer to such a sampling scheme as outcome and auxiliary-dependent subsampling (OADS). This paper is motivated by the need to analyze data from a lung cancer biomarker study that adopts the OADS design to assess EGFR mutations as a predictive biomarker for whether a subject responds to a greater extent to EGFR inhibitor drugs. We propose an estimated maximum likelihood method that accommodates the OADS design and utilizes all observed information, especially those contained in the likelihood score of EGFR mutations (an auxiliary variable of EGFR mutations) that is available to all patients. We derive the asymptotic properties of the proposed estimator and evaluate its finite sample properties via simulation. We illustrate the proposed method with a data example. Summary In cancer research, it is important to evaluate the performance of a biomarker (e.g., molecular, genetic, or imaging) that correlates patients' prognosis or predicts patients' response to treatment in a large prospective study. Due to overall budget constraint and high cost associated with bioassays, investigators often have to select a subset from all registered patients for biomarker assessment. To detect a potentially moderate association between the biomarker and the outcome, investigators need to decide how to select the subset of a fixed size such that the study efficiency can be enhanced. We show that, instead of drawing a simple random sample from the study cohort, greater efficiency can be achieved by allowing the selection probability to depend on the outcome and an auxiliary variable; we refer to such a sampling scheme as outcome and auxiliary‐dependent subsampling (OADS). This article is motivated by the need to analyze data from a lung cancer biomarker study that adopts the OADS design to assess epidermal growth factor receptor (EGFR) mutations as a predictive biomarker for whether a subject responds to a greater extent to EGFR inhibitor drugs. We propose an estimated maximum‐likelihood method that accommodates the OADS design and utilizes all observed information, especially those contained in the likelihood score of EGFR mutations (an auxiliary variable of EGFR mutations) that is available to all patients. We derive the asymptotic properties of the proposed estimator and evaluate its finite sample properties via simulation. We illustrate the proposed method with a data example. In cancer research, it is important to evaluate the performance of a biomarker (e.g., molecular, genetic, or imaging) that correlates patients' prognosis or predicts patients' response to treatment in a large prospective study. Due to overall budget constraint and high cost associated with bioassays, investigators often have to select a subset from all registered patients for biomarker assessment. To detect a potentially moderate association between the biomarker and the outcome, investigators need to decide how to select the subset of a fixed size such that the study efficiency can be enhanced. We show that, instead of drawing a simple random sample from the study cohort, greater efficiency can be achieved by allowing the selection probability to depend on the outcome and an auxiliary variable; we refer to such a sampling scheme as,outcome and auxiliary-dependent subsampling,(OADS). This article is motivated by the need to analyze data from a lung cancer biomarker study that adopts the OADS design to assess epidermal growth factor receptor (EGFR) mutations as a predictive biomarker for whether a subject responds to a greater extent to EGFR inhibitor drugs. We propose an estimated maximum-likelihood method that accommodates the OADS design and utilizes all observed information, especially those contained in the likelihood score of EGFR mutations (an auxiliary variable of EGFR mutations) that is available to all patients. We derive the asymptotic properties of the proposed estimator and evaluate its finite sample properties via simulation. We illustrate the proposed method with a data example. In cancer research, it is important to evaluate the performance of a biomarker (e.g., molecular, genetic, or imaging) that correlates patients' prognosis or predicts patients' response to treatment in a large prospective study. Due to overall budget constraint and high cost associated with bioassays, investigators often have to select a subset from all registered patients for biomarker assessment. To detect a potentially moderate association between the biomarker and the outcome, investigators need to decide how to select the subset of a fixed size such that the study efficiency can be enhanced. We show that, instead of drawing a simple random sample from the study cohort, greater efficiency can be achieved by allowing the selection probability to depend on the outcome and an auxiliary variable; we refer to such a sampling scheme as outcome and auxiliary-dependent subsampling (OADS). This article is motivated by the need to analyze data from a lung cancer biomarker study that adopts the OADS design to assess epidermal growth factor receptor (EGFR) mutations as a predictive biomarker for whether a subject responds to a greater extent to EGFR inhibitor drugs. We propose an estimated maximum-likelihood method that accommodates the OADS design and utilizes all observed information, especially those contained in the likelihood score of EGFR mutations (an auxiliary variable of EGFR mutations) that is available to all patients. We derive the asymptotic properties of the proposed estimator and evaluate its finite sample properties via simulation. We illustrate the proposed method with a data example. [PUBLICATION ABSTRACT] In cancer research, it is important to evaluate the performance of a biomarker (e.g., molecular, genetic, or imaging) that correlates patients' prognosis or predicts patients' response to treatment in a large prospective study. Due to overall budget constraint and high cost associated with bioassays, investigators often have to select a subset from all registered patients for biomarker assessment. To detect a potentially moderate association between the biomarker and the outcome, investigators need to decide how to select the subset of a fixed size such that the study efficiency can be enhanced. We show that, instead of drawing a simple random sample from the study cohort, greater efficiency can be achieved by allowing the selection probability to depend on the outcome and an auxiliary variable; we refer to such a sampling scheme as outcome and auxiliary-dependent subsampling (OADS). This article is motivated by the need to analyze data from a lung cancer biomarker study that adopts the OADS design to assess epidermal growth factor receptor (EGFR) mutations as a predictive biomarker for whether a subject responds to a greater extent to EGFR inhibitor drugs. We propose an estimated maximumlikelihood method that accommodates the OADS design and utilizes all observed information, especially those contained in the likelihood score of EGFR mutations (an auxiliary variable of EGFR mutations) that is available to all patients. We derive the asymptotic properties of the proposed estimator and evaluate its finite sample properties via simulation. We illustrate the proposed method with a data example. In cancer research, it is important to evaluate the performance of a biomarker (e.g., molecular, genetic, or imaging) that correlates patients' prognosis or predicts patients' response to treatment in a large prospective study. Due to overall budget constraint and high cost associated with bioassays, investigators often have to select a subset from all registered patients for biomarker assessment. To detect a potentially moderate association between the biomarker and the outcome, investigators need to decide how to select the subset of a fixed size such that the study efficiency can be enhanced. We show that, instead of drawing a simple random sample from the study cohort, greater efficiency can be achieved by allowing the selection probability to depend on the outcome and an auxiliary variable; we refer to such a sampling scheme as outcome and auxiliary-dependent subsampling (OADS). This article is motivated by the need to analyze data from a lung cancer biomarker study that adopts the OADS design to assess epidermal growth factor receptor (EGFR) mutations as a predictive biomarker for whether a subject responds to a greater extent to EGFR inhibitor drugs. We propose an estimated maximum-likelihood method that accommodates the OADS design and utilizes all observed information, especially those contained in the likelihood score of EGFR mutations (an auxiliary variable of EGFR mutations) that is available to all patients. We derive the asymptotic properties of the proposed estimator and evaluate its finite sample properties via simulation. We illustrate the proposed method with a data example.In cancer research, it is important to evaluate the performance of a biomarker (e.g., molecular, genetic, or imaging) that correlates patients' prognosis or predicts patients' response to treatment in a large prospective study. Due to overall budget constraint and high cost associated with bioassays, investigators often have to select a subset from all registered patients for biomarker assessment. To detect a potentially moderate association between the biomarker and the outcome, investigators need to decide how to select the subset of a fixed size such that the study efficiency can be enhanced. We show that, instead of drawing a simple random sample from the study cohort, greater efficiency can be achieved by allowing the selection probability to depend on the outcome and an auxiliary variable; we refer to such a sampling scheme as outcome and auxiliary-dependent subsampling (OADS). This article is motivated by the need to analyze data from a lung cancer biomarker study that adopts the OADS design to assess epidermal growth factor receptor (EGFR) mutations as a predictive biomarker for whether a subject responds to a greater extent to EGFR inhibitor drugs. We propose an estimated maximum-likelihood method that accommodates the OADS design and utilizes all observed information, especially those contained in the likelihood score of EGFR mutations (an auxiliary variable of EGFR mutations) that is available to all patients. We derive the asymptotic properties of the proposed estimator and evaluate its finite sample properties via simulation. We illustrate the proposed method with a data example. |
| Author | Wang, Xiaofei Zhou, Haibo |
| AuthorAffiliation | 1 Department of Biostatistics and Bioinformatics, Cancer Leukemia Group B Statistical Center, Duke University Medical Center, DUMC 2721, Durham, N.C. 27710, U.S.A 2 Department of Biostatistics, University of North Carolina at Chapel Hill Chapel Hill, N.C. 27599-7420, U.S.A |
| AuthorAffiliation_xml | – name: 1 Department of Biostatistics and Bioinformatics, Cancer Leukemia Group B Statistical Center, Duke University Medical Center, DUMC 2721, Durham, N.C. 27710, U.S.A – name: 2 Department of Biostatistics, University of North Carolina at Chapel Hill Chapel Hill, N.C. 27599-7420, U.S.A |
| Author_xml | – sequence: 1 givenname: Xiaofei surname: Wang fullname: Wang, Xiaofei – sequence: 2 givenname: Haibo surname: Zhou fullname: Zhou, Haibo |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19508239$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVUltv0zAYjdAQu8BPACJe4CXFtyT2y6RdYKu0rUhlgrdPruN0Lqld7IS1_x5nrVrYAxp58Wedi75znMNkzzqrkyTFaIDj93E2wDnDGWIEDQhCYoAw4WiwfJYcbIG95AAhVGSU4e_7yWEIs3gVOSIvkn0cT06oOEjUuQ5malNpq3Roa-21VTqtnU_PZJx8emrcXPofcRq3XbVK7017F9npqGuVm-sH4Um3NI2RfpWd64W2lbZtOu4mQc4XjbHTl8nzWjZBv9qcR8nt509fzy6zq9HF8OzkKlMF5igTiquST1iBEcJS5kwWpeSlnlCBK10RUrM6FxUXSLAJq6gWOa0Er5lWZaUUoUeJWPt2diFX97JpYOFN3H4FGEFfHMyg7wf6fqAvDh6Kg2XUHq-1i24y15WKEbzc6Z008DdizR1M3S8gXGBCWDR4vzHw7menQwtzE5RuGmm16wKUlLKcc5JH5od_MnFR8jwuSHCkvntEnbnO21gi0LwQuCS0j_3mz9V3mTePvMumvAvB6xqUaWVrXJ_ENE8phz8y-P9e702jV0_WwelwdN2P0eD12mAWWue3BgwVBY21Rzxb4ya0ernF4y8LRUnLHL7dXMDNpfhyTUoGfaVv1_xaOpBTbwLcjgnCFGHORMEI_Q0zMgNw |
| CODEN | BIOMA5 |
| CitedBy_id | crossref_primary_10_1007_s10985_015_9355_7 crossref_primary_10_1111_biom_12838 crossref_primary_10_1080_10543406_2017_1379532 crossref_primary_10_1111_j_1541_0420_2010_01430_x crossref_primary_10_1093_biostatistics_kxq080 crossref_primary_10_1007_s10985_020_09508_y crossref_primary_10_1093_biostatistics_kxs013 crossref_primary_10_1002_sim_7938 crossref_primary_10_1002_sim_7672 crossref_primary_10_1002_cjs_11131 crossref_primary_10_1002_pst_2087 crossref_primary_10_1016_j_jspi_2016_05_001 crossref_primary_10_1002_bimj_201500171 crossref_primary_10_1111_rssb_12029 crossref_primary_10_1002_cjs_11257 crossref_primary_10_1111_j_1541_0420_2011_01722_x crossref_primary_10_1093_biostatistics_kxab044 |
| Cites_doi | 10.1198/016214504000001853 10.1080/01621459.1952.10483446 10.1214/aos/1176349022 10.1097/EDE.0b013e31806462d3 10.1002/sim.4780110608 10.1002/sim.4780080407 10.1007/978-1-4899-4493-1 10.2307/1912755 10.1111/j.1467-9876.2005.00522.x 10.1093/biomet/66.3.403 10.2307/2533378 10.1093/biomet/80.2.339 10.1093/biomet/73.1.1 10.1056/NEJMoa040938 10.1111/1467-9876.00165 10.1200/JCO.2007.12.9858 10.1002/sim.4780100509 10.1093/biomet/75.1.11 10.1111/j.0006-341X.2002.00413.x 10.1093/biomet/82.1.139 10.1111/j.1541-0420.2006.00612.x 10.1111/1467-9868.00255 10.1111/1467-9868.00078 10.1137/1110024 10.1126/science.1099314 10.1093/biomet/78.4.705 10.1093/biomet/asn073 10.1093/oxfordjournals.aje.a113266 10.1201/9781482273144 10.1080/01621459.1991.10475009 10.1111/j.0006-341X.2002.00352.x |
| ContentType | Journal Article |
| Copyright | 2010 The International Biometric Society 2009, The International Biometric Society 2010 International Biometric Society |
| Copyright_xml | – notice: 2010 The International Biometric Society – notice: 2009, The International Biometric Society – notice: 2010 International Biometric Society |
| DBID | FBQ BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM JQ2 7S9 L.6 7X8 5PM ADTOC UNPAY |
| DOI | 10.1111/j.1541-0420.2009.01280.x |
| DatabaseName | AGRIS Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Computer Science Collection AGRICOLA AGRICOLA - Academic MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Computer Science Collection AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
| DatabaseTitleList | MEDLINE CrossRef AGRICOLA ProQuest Computer Science Collection MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 4 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Statistics Biology Mathematics |
| EISSN | 1541-0420 |
| EndPage | 511 |
| ExternalDocumentID | oai:pubmedcentral.nih.gov:2891224 PMC2891224 2048573881 19508239 10_1111_j_1541_0420_2009_01280_x BIOM1280 40663243 ark_67375_WNG_NH9PM274_1 US201301849642 |
| Genre | article Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: R03 CA131596 – fundername: NCRR NIH HHS grantid: UL1 RR024128 – fundername: NCI NIH HHS grantid: R01 CA079949 – fundername: NCI NIH HHS grantid: CA-79949 – fundername: NCI NIH HHS grantid: CA-131596 – fundername: NCRR NIH HHS grantid: UL1-RR024128 |
| GroupedDBID | --- -~X .3N .4S .DC .GA .GJ .Y3 05W 0R~ 10A 1OC 23N 2AX 2QV 3-9 31~ 33P 36B 3SF 3V. 4.4 44B 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 88E 88I 8AF 8C1 8FE 8FG 8FH 8FI 8FJ 8R4 8R5 8UM 930 A03 A8Z AAESR AAEVG AAHHS AAJUZ AANLZ AAONW AASGY AAXRX AAZKR ABBHK ABCQN ABCUV ABCVL ABDBF ABEML ABFAN ABHUG ABJCF ABJNI ABLJU ABPPZ ABPTK ABPVW ABTAH ABUWG ABWRO ABYWD ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOD ACIWK ACKIV ACMTB ACNCT ACPOU ACPRK ACSCC ACTMH ACXBN ACXME ACXQS ADAWD ADBBV ADDAD ADEOM ADIPN ADIZJ ADKYN ADMGS ADODI ADOZA ADULT ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AELPN AENEX AEQDE AEUPB AEUQT AEUYR AFBPY AFDVO AFEBI AFFTP AFGKR AFKRA AFPWT AFVGU AFVYC AFXKK AFZJQ AGJLS AGTJU AHMBA AIAGR AIBGX AIURR AIWBW AJBDE AJXKR ALAGY ALEEW ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ANPLD APXXL ARAPS ARCSS ASPBG AS~ ATUGU AUFTA AVWKF AZBYB AZFZN AZQEC AZVAB BAFTC BBNVY BCRHZ BDRZF BENPR BFHJK BGLVJ BHBCM BHPHI BMNLL BMXJE BNHUX BPHCQ BROTX BRXPI BVXVI BY8 CAG CCPQU COF CS3 D-E D-F DCZOG DPXWK DQDLB DR2 DRFUL DRSTM DSRWC DWQXO DXH EAD EAP EBC EBD EBS ECEWR EDO EFSUC EJD EMB EMK EMOBN EST ESTFP ESX F00 F01 F04 F5P FBQ FD6 FEDTE FXEWX FYUFA G-S G.N GNUQQ GODZA GS5 H.T H.X HCIFZ HF~ HGD HMCUK HQ6 HVGLF HZI HZ~ IHE IX1 J0M JAAYA JAC JBMMH JBZCM JENOY JHFFW JKQEH JLEZI JLXEF JMS JPL JSODD JST K48 K6V K7- L6V LATKE LC2 LC3 LEEKS LH4 LITHE LK8 LOXES LP6 LP7 LUTES LW6 LYRES M1P M2P M7P M7S MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MVM MXFUL MXSTM N04 N05 N9A NF~ NHB O66 O9- OWPYF P0- P2P P2W P2X P4D P62 PQQKQ PROAC PSQYO PTHSS Q.N Q11 Q2X QB0 R.K RNS ROL RWL RX1 RXW SA0 SUPJJ SV3 TAE TN5 TUS UAP UB1 UKHRP V8K VQA W8V W99 WBKPD WH7 WIH WIK WOHZO WQJ WRC WXSBR WYISQ X6Y XBAML XFK XG1 XSW ZGI ZXP ZY4 ZZTAW ~02 ~IA ~KM ~WT AAHBH AAMMB AANHP AAUAY AAWIL AAYCA AAZSN ABAWQ ABDFA ABEJV ABGNP ABMNT ABXSQ ABXVV ACHJO ACRPL ACUHS ACYXJ ADNBA ADNMO ADVOB AEFGJ AEOTA AFWVQ AGLNM AGQPQ AGXDD AHGBF AIDQK AIDYY AIHAF AJAOE AJBYB AJNCP ALRMG BSCLL H13 IPSME KOP NU- OIG OJZSN PHGZM PHGZT PJZUB PPXIY PQGLB PUEGO ROX AGORE ALIPV AAYXX CITATION CGR CUY CVF ECM EIF NPM JQ2 7S9 L.6 7X8 5PM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c6180-9c8c78b461001aa54a67a87eb391ded22f4f59d89094b4d3e953d98f4ec7dcc23 |
| IEDL.DBID | DR2 |
| ISSN | 0006-341X 1541-0420 |
| IngestDate | Sun Oct 26 04:13:29 EDT 2025 Tue Sep 30 16:47:09 EDT 2025 Thu Oct 02 10:53:23 EDT 2025 Fri Oct 03 00:00:23 EDT 2025 Wed Aug 13 11:21:46 EDT 2025 Mon Jul 21 06:03:50 EDT 2025 Thu Apr 24 22:58:51 EDT 2025 Wed Oct 01 01:41:24 EDT 2025 Wed Jan 22 16:46:15 EST 2025 Thu Jul 03 21:22:34 EDT 2025 Sun Sep 21 06:19:35 EDT 2025 Wed Dec 27 19:17:40 EST 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c6180-9c8c78b461001aa54a67a87eb391ded22f4f59d89094b4d3e953d98f4ec7dcc23 |
| Notes | http://dx.doi.org/10.1111/j.1541-0420.2009.01280.x istex:CEC0582D6626D249BD3808ECC868CE02E232C8C4 ark:/67375/WNG-NH9PM274-1 ArticleID:BIOM1280 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=http://doi.org/10.1111/j.1541-0420.2009.01280.x |
| PMID | 19508239 |
| PQID | 356917232 |
| PQPubID | 35366 |
| PageCount | 10 |
| ParticipantIDs | unpaywall_primary_10_1111_j_1541_0420_2009_01280_x pubmedcentral_primary_oai_pubmedcentral_nih_gov_2891224 proquest_miscellaneous_733458825 proquest_miscellaneous_1678542021 proquest_journals_356917232 pubmed_primary_19508239 crossref_citationtrail_10_1111_j_1541_0420_2009_01280_x crossref_primary_10_1111_j_1541_0420_2009_01280_x wiley_primary_10_1111_j_1541_0420_2009_01280_x_BIOM1280 jstor_primary_40663243 istex_primary_ark_67375_WNG_NH9PM274_1 fao_agris_US201301849642 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | June 2010 |
| PublicationDateYYYYMMDD | 2010-06-01 |
| PublicationDate_xml | – month: 06 year: 2010 text: June 2010 |
| PublicationDecade | 2010 |
| PublicationPlace | Malden, USA |
| PublicationPlace_xml | – name: Malden, USA – name: England – name: Washington |
| PublicationTitle | Biometrics |
| PublicationTitleAlternate | Biometrics |
| PublicationYear | 2010 |
| Publisher | Blackwell Publishing Inc Wiley-Blackwell Blackwell Publishing Ltd |
| Publisher_xml | – name: Blackwell Publishing Inc – name: Wiley-Blackwell – name: Blackwell Publishing Ltd |
| References | Wacholder, S. and Weinberg, C. R. (1994). Flexible maximum likelihood methods for assessing joint effects in case-control studies with complex sampling. Biometrics 50, 350-357. Zhou, H., Chen, J., and Cai, J. (2002). Random effects logistic regression analysis with auxiliary covariates. Biometrics 58, 352-360. Baker, S. G. and Kramer, B. S. (2005). Statistics for weighing benefits and harms in a proposed genetic substudy of a randomized cancer prevention trial. Journal of the Royal Statistical Society, Series C 54, 941-954. Weaver, M. A. and Zhou, H. (2005). An estimated likelihood method for continuous outcome regression models with outcome-dependent sampling. Journal of the American Statistical Association 100, 459-469. Breslow, N. E. and Cain, K. C. (1988). Logistic regression for two-stage case-control data. Biometrika 75, 11-20. Zhao, L. P. and Lipsitz, S. (1992). Designs and analysis of two-stage studies. Statistics in Medicine 11, 769-782. Fan, J. (1993). Local linear regression smoothers and their minimax efficiencies. Annals of Statistics 21, 196-216. Wild, C. J. (1991). Fitting prospective regression models to case-control data. Biometrika 78, 705-717. Prentice, R. L. and Pyke, R. (1979). Logistic disease incidence models and case control studies. Biometrika 66, 403-411. Horvitz, D. G. and Thompson, D. J. (1952). A generalization of sampling without replacement from a finite universe. Journal of the American Statistical Association 47, 663-685. Nadaraya, E. A. (1964). On estimating regression. Theory of Probability and Its Applications 10, 186-190. Eubank, R. L. (1999). Nonparametric Regression and Spline Smoothing. New York : Marcel Dekker, Inc. Breslow, N. E. and Day, N. E. (1980). Statistical Methods in Cancer Research I: The Analysis of Case-Control Studies. Lyon , France : International Agency for Research on Cancer . Paez, J. G., Jänne, P. A., and Lee J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., Naoki, K., Sasaki, H., Fujii, Y., Eck, M. J., Sellers, W. R., Johnson, B. E., and Meyerson, M. (2004). EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science 304, 1497-500. Breslow, N. C. and Holubkov, R. (1997). Maximum likelihood estimation of logistic regression parameters under two-phase, outcome-dependent sampling. Journal of the Royal Statistical Society, Series B 59, 447-461. Wand, M. P. and Jones, M. C. (1995). Kernel Smoothing. London : Chapman and Hall. Zhou, H., Weaver, M. A., Qin, J., Longnecker, M. P., and Wang, M. C. (2002). A semiparametric empirical likelihood method for data from an outcome-dependent sampling design with a continuous outcome. Biometrics 58, 413-421. Zhou, H., Chen, J., Rissanen, T., Korrick, S., Hu, H., Salonen, J. T., and Longnecker, M. P. (2007). An efficient sampling and inference procedure for studies with a continuous outcome. Epidemiology 18, 461-468. Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., Louis, D. N., Christiani, D. C., Settleman, J., and Haber, D. A. (2004). Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. New England Journal of Medicine 350, 2129-2139. Song, R., Zhou, H., and Kosorok, M. R. (2009). A note on semiparametric efficient inference for two-stage outcome-dependent sampling with a continuous outcome. Biometrika 96, 221-228. Wang, X. F. and Zhou, H. (2006). A semiparametric empirical likelihood method for biased sampling schemes in epidemiologic studies with auxiliary covariates. Biometrics 62, 1149-1160. Pepe, M. S. and Fleming, R. R. (1991). A nonparametric method for dealing with mismeasured covariate data. Journal of the American Statistical Association 86, 108-113. Zhou, H. and Wang, C. Y. (2000). Failure time regression analysis with measurement error in Covariates. Journal of the Royal Statistical Society, Series B 62, 657-665. Eberhard, D. A., Giaccone, G., Johnson, B. E. on behalf of the Molecular Assays in Non-Small-Cell Lung Cancer Working Group. (2008). Biomarkers of response to epidermal growth factor receptor inhibitors in non-small-cell lung cancer: Standardization for use in the clinical trial setting. Journal of Clinical Oncology 26, 983-994. Flanders, W. D. and Greenland, S. (1991). Analytic methods for two-stage case-control studies and other stratified designs. Statistics in Medicine 10, 739-747. Cosslett, S. R. (1981). Maximum likelihood estimator for choice-based samples. Econometrica 49, 1289-1316. Schill, W., Jöckel, K.-H., Drescher, K., and Timm, J. (1993). Logistic analysis in case-control studies under validation sampling. Biometrika 80, 339-352. Watson, G. S. (1964). Smooth regression analysis. Sankhya, Series A 26, 359-372. Breslow, N. E. and Chatterjee, N. (1999). Design and analysis of two-phase studies with binary outcome applied to Wilms tumor prognosis. Applied Statistics 48, 457-468. White, J. E. (1982). A two stage design for the study of the relationship between a rare exposure and a rare disease. American Journal of Epidemiology 115, 119-128. Carroll, R. J. and Wand, M. P. (1991). Semiparametric estimation in logistic measurement error models. Journal of the Royal Statistical Society, Series B 53, 573-585. Zhou, H. and Pepe, M. S. (1995). Auxiliary covariate data in failure time regression. Biometrika 82, 139-149. Prentice, R. L. (1986). A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 73, 1-11. Prentice, R. L. (1989). Surrogate endpoints in clinical trials: Definition and operational criteria. Statistics in Medicine 8, 431-440. Maddaus, M. A., Wang, X. F., Vollmer, R. T., Abraham, N. Z., D'Cunha, J., Herzan, D. L., Patterson, A., Kohman, L. J., Green, M. R., and Kratzke, R. A. (2006). CALGB 9761: A prospective analysis of IHC and PCR based detection of occult metastatic disease in stage I NSCLC. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 7030. 2007; 18 2002; 58 1986; 73 1991; 78 1991; 10 1991; 53 1993; 21 1999; 48 1989; 8 1981; 49 2006 1995 1964; 26 1988; 75 1992; 11 2004; 304 1999 1952; 47 2009; 96 1995; 82 2006; 62 2005; 100 1997; 59 2004; 350 1991; 86 1964; 10 2008; 26 2000; 62 2005; 54 1993; 80 1982; 115 1980 1979; 66 1994; 50 e_1_2_9_30_1 e_1_2_9_31_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_12_1 e_1_2_9_33_1 Carroll R. J. (e_1_2_9_7_1) 1991; 53 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_36_1 Breslow N. E. (e_1_2_9_6_1) 1980 e_1_2_9_16_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_20_1 e_1_2_9_22_1 e_1_2_9_21_1 e_1_2_9_24_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 e_1_2_9_28_1 Watson G. S. (e_1_2_9_27_1) 1964; 26 e_1_2_9_29_1 Maddaus M. A. (e_1_2_9_15_1) 2006 |
| References_xml | – reference: Watson, G. S. (1964). Smooth regression analysis. Sankhya, Series A 26, 359-372. – reference: Paez, J. G., Jänne, P. A., and Lee J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., Naoki, K., Sasaki, H., Fujii, Y., Eck, M. J., Sellers, W. R., Johnson, B. E., and Meyerson, M. (2004). EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science 304, 1497-500. – reference: Prentice, R. L. (1989). Surrogate endpoints in clinical trials: Definition and operational criteria. Statistics in Medicine 8, 431-440. – reference: Wacholder, S. and Weinberg, C. R. (1994). Flexible maximum likelihood methods for assessing joint effects in case-control studies with complex sampling. Biometrics 50, 350-357. – reference: Fan, J. (1993). Local linear regression smoothers and their minimax efficiencies. Annals of Statistics 21, 196-216. – reference: Breslow, N. E. and Day, N. E. (1980). Statistical Methods in Cancer Research I: The Analysis of Case-Control Studies. Lyon , France : International Agency for Research on Cancer . – reference: Maddaus, M. A., Wang, X. F., Vollmer, R. T., Abraham, N. Z., D'Cunha, J., Herzan, D. L., Patterson, A., Kohman, L. J., Green, M. R., and Kratzke, R. A. (2006). CALGB 9761: A prospective analysis of IHC and PCR based detection of occult metastatic disease in stage I NSCLC. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 7030. – reference: Horvitz, D. G. and Thompson, D. J. (1952). A generalization of sampling without replacement from a finite universe. Journal of the American Statistical Association 47, 663-685. – reference: Flanders, W. D. and Greenland, S. (1991). Analytic methods for two-stage case-control studies and other stratified designs. Statistics in Medicine 10, 739-747. – reference: Cosslett, S. R. (1981). Maximum likelihood estimator for choice-based samples. Econometrica 49, 1289-1316. – reference: Eberhard, D. A., Giaccone, G., Johnson, B. E. on behalf of the Molecular Assays in Non-Small-Cell Lung Cancer Working Group. (2008). Biomarkers of response to epidermal growth factor receptor inhibitors in non-small-cell lung cancer: Standardization for use in the clinical trial setting. Journal of Clinical Oncology 26, 983-994. – reference: Wang, X. F. and Zhou, H. (2006). A semiparametric empirical likelihood method for biased sampling schemes in epidemiologic studies with auxiliary covariates. Biometrics 62, 1149-1160. – reference: Zhou, H., Weaver, M. A., Qin, J., Longnecker, M. P., and Wang, M. C. (2002). A semiparametric empirical likelihood method for data from an outcome-dependent sampling design with a continuous outcome. Biometrics 58, 413-421. – reference: Breslow, N. E. and Cain, K. C. (1988). Logistic regression for two-stage case-control data. Biometrika 75, 11-20. – reference: Prentice, R. L. and Pyke, R. (1979). Logistic disease incidence models and case control studies. Biometrika 66, 403-411. – reference: Zhao, L. P. and Lipsitz, S. (1992). Designs and analysis of two-stage studies. Statistics in Medicine 11, 769-782. – reference: Breslow, N. E. and Chatterjee, N. (1999). Design and analysis of two-phase studies with binary outcome applied to Wilms tumor prognosis. Applied Statistics 48, 457-468. – reference: Zhou, H. and Pepe, M. S. (1995). Auxiliary covariate data in failure time regression. Biometrika 82, 139-149. – reference: Zhou, H., Chen, J., Rissanen, T., Korrick, S., Hu, H., Salonen, J. T., and Longnecker, M. P. (2007). An efficient sampling and inference procedure for studies with a continuous outcome. Epidemiology 18, 461-468. – reference: Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., Louis, D. N., Christiani, D. C., Settleman, J., and Haber, D. A. (2004). Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. New England Journal of Medicine 350, 2129-2139. – reference: Zhou, H. and Wang, C. Y. (2000). Failure time regression analysis with measurement error in Covariates. Journal of the Royal Statistical Society, Series B 62, 657-665. – reference: Weaver, M. A. and Zhou, H. (2005). An estimated likelihood method for continuous outcome regression models with outcome-dependent sampling. Journal of the American Statistical Association 100, 459-469. – reference: Wand, M. P. and Jones, M. C. (1995). Kernel Smoothing. London : Chapman and Hall. – reference: Baker, S. G. and Kramer, B. S. (2005). Statistics for weighing benefits and harms in a proposed genetic substudy of a randomized cancer prevention trial. Journal of the Royal Statistical Society, Series C 54, 941-954. – reference: Schill, W., Jöckel, K.-H., Drescher, K., and Timm, J. (1993). Logistic analysis in case-control studies under validation sampling. Biometrika 80, 339-352. – reference: White, J. E. (1982). A two stage design for the study of the relationship between a rare exposure and a rare disease. American Journal of Epidemiology 115, 119-128. – reference: Breslow, N. C. and Holubkov, R. (1997). Maximum likelihood estimation of logistic regression parameters under two-phase, outcome-dependent sampling. Journal of the Royal Statistical Society, Series B 59, 447-461. – reference: Wild, C. J. (1991). Fitting prospective regression models to case-control data. Biometrika 78, 705-717. – reference: Pepe, M. S. and Fleming, R. R. (1991). A nonparametric method for dealing with mismeasured covariate data. Journal of the American Statistical Association 86, 108-113. – reference: Prentice, R. L. (1986). A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 73, 1-11. – reference: Carroll, R. J. and Wand, M. P. (1991). Semiparametric estimation in logistic measurement error models. Journal of the Royal Statistical Society, Series B 53, 573-585. – reference: Zhou, H., Chen, J., and Cai, J. (2002). Random effects logistic regression analysis with auxiliary covariates. Biometrics 58, 352-360. – reference: Eubank, R. L. (1999). Nonparametric Regression and Spline Smoothing. New York : Marcel Dekker, Inc. – reference: Song, R., Zhou, H., and Kosorok, M. R. (2009). A note on semiparametric efficient inference for two-stage outcome-dependent sampling with a continuous outcome. Biometrika 96, 221-228. – reference: Nadaraya, E. A. (1964). On estimating regression. Theory of Probability and Its Applications 10, 186-190. – volume: 18 start-page: 461 year: 2007 end-page: 468 article-title: An efficient sampling and inference procedure for studies with a continuous outcome publication-title: Epidemiology – volume: 21 start-page: 196 year: 1993 end-page: 216 article-title: Local linear regression smoothers and their minimax efficiencies publication-title: Annals of Statistics – volume: 49 start-page: 1289 year: 1981 end-page: 1316 article-title: Maximum likelihood estimator for choice‐based samples publication-title: Econometrica – volume: 75 start-page: 11 year: 1988 end-page: 20 article-title: Logistic regression for two‐stage case‐control data publication-title: Biometrika – year: 2006 article-title: CALGB 9761: A prospective analysis of IHC and PCR based detection of occult metastatic disease in stage I NSCLC publication-title: Journal of Clinical Oncology – volume: 304 start-page: 1497 year: 2004 end-page: 500 article-title: EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy publication-title: Science – volume: 10 start-page: 186 year: 1964 end-page: 190 article-title: On estimating regression publication-title: Theory of Probability and Its Applications – volume: 47 start-page: 663 year: 1952 end-page: 685 article-title: A generalization of sampling without replacement from a finite universe publication-title: Journal of the American Statistical Association – volume: 96 start-page: 221 year: 2009 end-page: 228 article-title: A note on semiparametric efficient inference for two‐stage outcome‐dependent sampling with a continuous outcome publication-title: Biometrika – volume: 54 start-page: 941 year: 2005 end-page: 954 article-title: Statistics for weighing benefits and harms in a proposed genetic substudy of a randomized cancer prevention trial publication-title: Journal of the Royal Statistical Society, Series C – volume: 59 start-page: 447 year: 1997 end-page: 461 article-title: Maximum likelihood estimation of logistic regression parameters under two‐phase, outcome‐dependent sampling publication-title: Journal of the Royal Statistical Society, Series B – volume: 62 start-page: 1149 year: 2006 end-page: 1160 article-title: A semiparametric empirical likelihood method for biased sampling schemes in epidemiologic studies with auxiliary covariates publication-title: Biometrics – volume: 26 start-page: 359 year: 1964 end-page: 372 article-title: Smooth regression analysis publication-title: Sankhya, Series A – volume: 82 start-page: 139 year: 1995 end-page: 149 article-title: Auxiliary covariate data in failure time regression publication-title: Biometrika – volume: 58 start-page: 413 year: 2002 end-page: 421 article-title: A semiparametric empirical likelihood method for data from an outcome‐dependent sampling design with a continuous outcome publication-title: Biometrics – volume: 8 start-page: 431 year: 1989 end-page: 440 article-title: Surrogate endpoints in clinical trials: Definition and operational criteria publication-title: Statistics in Medicine – volume: 48 start-page: 457 year: 1999 end-page: 468 article-title: Design and analysis of two‐phase studies with binary outcome applied to Wilms tumor prognosis publication-title: Applied Statistics – volume: 100 start-page: 459 year: 2005 end-page: 469 article-title: An estimated likelihood method for continuous outcome regression models with outcome‐dependent sampling publication-title: Journal of the American Statistical Association – volume: 50 start-page: 350 year: 1994 end-page: 357 article-title: Flexible maximum likelihood methods for assessing joint effects in case‐control studies with complex sampling publication-title: Biometrics – year: 1980 – volume: 115 start-page: 119 year: 1982 end-page: 128 article-title: A two stage design for the study of the relationship between a rare exposure and a rare disease publication-title: American Journal of Epidemiology – volume: 66 start-page: 403 year: 1979 end-page: 411 article-title: Logistic disease incidence models and case control studies publication-title: Biometrika – volume: 11 start-page: 769 year: 1992 end-page: 782 article-title: Designs and analysis of two‐stage studies publication-title: Statistics in Medicine – volume: 53 start-page: 573 year: 1991 end-page: 585 article-title: Semiparametric estimation in logistic measurement error models publication-title: Journal of the Royal Statistical Society, Series B – volume: 26 start-page: 983 year: 2008 end-page: 994 article-title: Biomarkers of response to epidermal growth factor receptor inhibitors in non‐small‐cell lung cancer: Standardization for use in the clinical trial setting publication-title: Journal of Clinical Oncology – year: 1995 – volume: 10 start-page: 739 year: 1991 end-page: 747 article-title: Analytic methods for two‐stage case‐control studies and other stratified designs publication-title: Statistics in Medicine – volume: 80 start-page: 339 year: 1993 end-page: 352 article-title: Logistic analysis in case‐control studies under validation sampling publication-title: Biometrika – volume: 78 start-page: 705 year: 1991 end-page: 717 article-title: Fitting prospective regression models to case‐control data publication-title: Biometrika – volume: 62 start-page: 657 year: 2000 end-page: 665 article-title: Failure time regression analysis with measurement error in Covariates publication-title: Journal of the Royal Statistical Society, Series B – volume: 350 start-page: 2129 year: 2004 end-page: 2139 article-title: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non‐small‐cell lung cancer to gefitinib publication-title: New England Journal of Medicine – volume: 58 start-page: 352 year: 2002 end-page: 360 article-title: Random effects logistic regression analysis with auxiliary covariates publication-title: Biometrics – volume: 86 start-page: 108 year: 1991 end-page: 113 article-title: A nonparametric method for dealing with mismeasured covariate data publication-title: Journal of the American Statistical Association – volume: 73 start-page: 1 year: 1986 end-page: 11 article-title: A case‐cohort design for epidemiologic cohort studies and disease prevention trials publication-title: Biometrika – year: 1999 – ident: e_1_2_9_28_1 doi: 10.1198/016214504000001853 – ident: e_1_2_9_13_1 doi: 10.1080/01621459.1952.10483446 – ident: e_1_2_9_11_1 doi: 10.1214/aos/1176349022 – ident: e_1_2_9_35_1 doi: 10.1097/EDE.0b013e31806462d3 – ident: e_1_2_9_31_1 doi: 10.1002/sim.4780110608 – ident: e_1_2_9_20_1 doi: 10.1002/sim.4780080407 – ident: e_1_2_9_25_1 doi: 10.1007/978-1-4899-4493-1 – ident: e_1_2_9_8_1 doi: 10.2307/1912755 – ident: e_1_2_9_2_1 doi: 10.1111/j.1467-9876.2005.00522.x – ident: e_1_2_9_21_1 doi: 10.1093/biomet/66.3.403 – ident: e_1_2_9_24_1 doi: 10.2307/2533378 – ident: e_1_2_9_22_1 doi: 10.1093/biomet/80.2.339 – ident: e_1_2_9_19_1 doi: 10.1093/biomet/73.1.1 – volume: 53 start-page: 573 year: 1991 ident: e_1_2_9_7_1 article-title: Semiparametric estimation in logistic measurement error models publication-title: Journal of the Royal Statistical Society, Series B – ident: e_1_2_9_14_1 doi: 10.1056/NEJMoa040938 – ident: e_1_2_9_5_1 doi: 10.1111/1467-9876.00165 – ident: e_1_2_9_9_1 doi: 10.1200/JCO.2007.12.9858 – ident: e_1_2_9_12_1 doi: 10.1002/sim.4780100509 – ident: e_1_2_9_4_1 doi: 10.1093/biomet/75.1.11 – ident: e_1_2_9_36_1 doi: 10.1111/j.0006-341X.2002.00413.x – ident: e_1_2_9_32_1 doi: 10.1093/biomet/82.1.139 – ident: e_1_2_9_26_1 doi: 10.1111/j.1541-0420.2006.00612.x – ident: e_1_2_9_33_1 doi: 10.1111/1467-9868.00255 – ident: e_1_2_9_3_1 doi: 10.1111/1467-9868.00078 – volume-title: Statistical Methods in Cancer Research I: The Analysis of Case‐Control Studies year: 1980 ident: e_1_2_9_6_1 – ident: e_1_2_9_16_1 doi: 10.1137/1110024 – ident: e_1_2_9_17_1 doi: 10.1126/science.1099314 – ident: e_1_2_9_29_1 doi: 10.1093/biomet/78.4.705 – ident: e_1_2_9_23_1 doi: 10.1093/biomet/asn073 – year: 2006 ident: e_1_2_9_15_1 article-title: CALGB 9761: A prospective analysis of IHC and PCR based detection of occult metastatic disease in stage I NSCLC publication-title: Journal of Clinical Oncology – ident: e_1_2_9_30_1 doi: 10.1093/oxfordjournals.aje.a113266 – volume: 26 start-page: 359 year: 1964 ident: e_1_2_9_27_1 article-title: Smooth regression analysis publication-title: Sankhya, Series A – ident: e_1_2_9_10_1 doi: 10.1201/9781482273144 – ident: e_1_2_9_18_1 doi: 10.1080/01621459.1991.10475009 – ident: e_1_2_9_34_1 doi: 10.1111/j.0006-341X.2002.00352.x |
| SSID | ssj0009502 |
| Score | 2.0397463 |
| Snippet | In cancer research, it is important to evaluate the performance of a biomarker (e.g., molecular, genetic, or imaging) that correlates patients' prognosis or... Summary In cancer research, it is important to evaluate the performance of a biomarker (e.g., molecular, genetic, or imaging) that correlates patients'... Summary In cancer research, it is important to evaluate the performance of a biomarker (e.g., molecular, genetic, or imaging) that correlates patients'... In cancer research, it is important to evaluate the performance of a biomarker (e.g. molecular, genetic, or imaging) that correlates patients’ prognosis or... |
| SourceID | unpaywall pubmedcentral proquest pubmed crossref wiley jstor istex fao |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 502 |
| SubjectTerms | Auxiliary variable bioassays Biological markers Biomarker Biomarkers Biomarkers, Tumor BIOMETRIC METHODOLOGY Biometrics biometry Cancer Clinical outcomes Computer Simulation Consistent estimators Data models Design efficiency drugs Efficiency Epidermal Growth Factor - antagonists & inhibitors Epidermal Growth Factor - genetics epidermal growth factor receptors Estimated likelihood method Estimation methods Estimators Genetic mutation Humans image analysis Inference Kernel smoother Lung neoplasms Lung Neoplasms - drug therapy Lung Neoplasms - genetics Methods Mutation Neoplasms - diagnosis Outcome and auxiliary-dependent subsampling Patient Selection patients Precision Medicine - methods Predictive Value of Tests probability Prognosis prospective studies Sampling techniques |
| SummonAdditionalLinks | – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB6VVIhy4BFauhSQkRC3RNm1vd49hpaSIiWNBBHhZHlfJSJsqiQrEk78BH4jv4SZfdGoRQrcIq3HyU7G4288n2cAXiZcBbFtRAv3LoEBCpqxoRMxbpQbck_wwKb7zv2B2xuJd2M53oGqM93V9H1JuJEC413hdMrakuhPO20EjbuuRPDdgN3RYNj9VIBct4U-eZxXSC2FNrk7N061sSHdSswMYSppeFUxFG_CntcplHey9NKsv5npdBPm5vvU6X0YVrd9CnrKl3a2DNrh9-vFH7dVwQO4V2JW1i2M7CHsxGkTbhddLNdNuNuvS78umrBH8LWo_vwI4pOcIMJMGrGz6mohQ5zMjsna5gwn-UoEoTkjQuOa0bEwjmbn2RKXQpwLdrPVZDox8_WvHz9Pyp69S0YezxAdPr3Yh9Hpmw_HvVbZ2KEVurbXafmhFyovoFLvHdsYKYyrjKcwrvftKI4cJxGJ9CPPx9gzEBGPfckj30tEHKooDB1-AI10lsaHwBIvsv3ESB6EUkQG8apy0MASdDOUUw4tUNW_q8Oy6jk135jqK9EP6leTfqknp69z_eqVBXYteVlU_thC5hANSJsLdNB69N6htDCG0D4GeRa8yq2qnguVS6Q6JfXHwVs96PnDvqOEti04yM2uHigIFeJLWXBU2aEuHc1Cc-liwI2w2IIX9VP0EJT2MWk8yxbaRjwi8Zc6ODX7yxjFOV1ZdqQFjwvD_vPO1CfY4T5qcsPk6wFUoHzzSTr5nBcqx2CeErcWOPXi-AdVqnwVbS2gX5-d9-njk__5uiPYK3ghdL72FBrLeRY_Q7i5DJ6XLuY36oJosg priority: 102 providerName: Unpaywall |
| Title | Design and Inference for Cancer Biomarker Study with an Outcome and Auxiliary-Dependent Subsampling |
| URI | https://api.istex.fr/ark:/67375/WNG-NH9PM274-1/fulltext.pdf https://www.jstor.org/stable/40663243 https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1541-0420.2009.01280.x https://www.ncbi.nlm.nih.gov/pubmed/19508239 https://www.proquest.com/docview/356917232 https://www.proquest.com/docview/1678542021 https://www.proquest.com/docview/733458825 https://pubmed.ncbi.nlm.nih.gov/PMC2891224 http://doi.org/10.1111/j.1541-0420.2009.01280.x |
| UnpaywallVersion | submittedVersion |
| Volume | 66 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate - TFS customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1541-0420 dateEnd: 20241103 omitProxy: true ssIdentifier: ssj0009502 issn: 0006-341X databaseCode: ABDBF dateStart: 20030301 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVEBS databaseName: EBSCOhost Food Science Source customDbUrl: eissn: 1541-0420 dateEnd: 20241103 omitProxy: false ssIdentifier: ssj0009502 issn: 0006-341X databaseCode: A8Z dateStart: 20030301 isFulltext: true titleUrlDefault: https://search.ebscohost.com/login.aspx?authtype=ip,uid&profile=ehost&defaultdb=fsr providerName: EBSCOhost – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0006-341X databaseCode: DR2 dateStart: 19990101 customDbUrl: isFulltext: true eissn: 1541-0420 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009502 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdgCDEe-CiMhcFkJMRbp8YfcfzYrpQOqd0EVJQny_ka1Uo6tY1oeeJP4G_kL-EuScMCQxqIt1axrfhyd_6dff4dIc8TroLYtaIJa5eAAAXU2OKOGLfKC7kveODifefB0OuPxOuxHJf5T3gXpuCHqDbc0DJyf40GboNF3cilgFBYsFZJOwmutnWAeNLlXh5dvWEX-HdbBXE4pnoJd1xP6rl0oNpKdT2xM8CvKPrVJnXxMlD6e27lrSw9t-vPdjqt4998AevdJWebqRd5K2cH2TI4CL_8wgr5f2Rzj9wpcS5tF4p5n1yL0wa5WVS-XDfI7UFFF7tokG2EvAVj9AMSd_OkEmrTiB5triNSwNb0EDV0TmGQT5hUNKeYBLmmuJUMrelxtoT3jPOO7Ww1mU5gAt-_fuuWdX6XFL2kxRT69PQhGfVevjvsN8tiEM3Qc_1WU4d-qPwA6eFbrrVSWE9ZX8UB124UR4wlIpE68jXEq4GIeKwlj7SfiDhUURgyvkO20lka7xKa-JGrEyt5EEoRWcC4ioFSJuCa8Bw6dIjafHgTlkzpWLBjai5ETCBfg_LFOp7a5PI1K4e4Vc_zgi3kCn12QbeMPQWnbkZvGR4lQ9itITB0yItc4aqxQLiYiKekeT98ZYZ9fTJgShjXITu5RlYNBSJJmJRD9jYqakrntDBcehCkA5R2yLPqKXgVPCqyaTzLFsYFDCPhTRkMTf_QRnGO15yZdMijQud_zhlrCzOuQZI1a6gaIKl5_Uk6-ZiTmzNf42GvQ1hlN38hSpVbxZU7mM7R8QB_Pv7nnntku0gowY25J2RrOc_ip4BTl8E-udHudDu9_dwTwb_R8KT94QevHYBP |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwED_BENp44KNsLIwPIyHeWjW2E8ePY2O0sHYINtE3y_kaFSWd2ka0PPEn8Dfyl3CXpGGFIQ3EW6TYVny5O__OPv8O4GkqVJi4VjZx7ZIYoKAaW9oRE1b5kQikCF2679zr-50T-WrgDapyQHQXpuSHqDfcyDIKf00GThvSq1buSYyFJW9XvJPoa9stBJTXpI9hCyGkt_wcA2-7pA6nZC_pDlbTei4caWWtupraMSJYEv58mbx4ESz9PbtyPc_O7OKzHY1WEXCxhB3cgtFy8mXmysdWPgtb0ZdfeCH_k3Ruw80K6rLdUjfvwJUka8D1svjlogE3ejVj7LQBG4R6S9Lou5DsF3klzGYx6y5vJDKE12yPlHTCcJBPlFc0YZQHuWC0m4yt2VE-ww9Nio67-Xw4GuIMvn_9tl-V-p0xcpSWsuiz0004OXhxvNdpVvUgmpHvBu2mjoJIBSExxLddaz1pfWUDlYRCu3ESc57K1NNxoDFkDWUsEu2JWAepTCIVRxEXW7CWjbNkG1gaxK5OrSfCyJOxRZirOOplit6JjqIjB9Tyz5uoIkunmh0jcy5oQvkaki-V8tSmkK-ZO-DWPc9KwpBL9NlG5TL2FP26OXnH6TQZI2-NsaEDzwqNq8dC4VIunvLM-_5L0-_oNz2upHEd2CpUsm4oCUzipBzYWeqoqfzT1AjPxzgd0bQDT-q36FjotMhmyTifGhdhjIdfynFo9oc2Sgi66cw9B-6VSv9zzlRemAuNklwxh7oB8ZqvvsmGHwp-cx5oOu91gNeG8xeiVIVZXLqDed496tHj_X_u-RjWO8e9Q3PY7b_egY0yv4T26R7A2mySJw8Rts7CR4U7-gGakYFO |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLZgCBgPXApjYVyMhHhr1fhSx49jpbRAuwmY6JvlJM6oKGnVNqLliZ_Ab-SXcE6ShhWGNBBvlWJb8enxyXfsz98h5EnCVeh8K-rw7RKQoIAbW9wR41a1Ih4IHvp437k_aHWPxcuhHJblgPAuTKEPUW244crI4zUucDeNk81VLgXkwoI1S91JiLXNBgDKS0LqAPl97TfslAJvs5AOR7KX8IebtJ4zR9r4Vl1M7AQQLBp_uSYvngVLf2dXXs3SqV19tuPxJgLOP2GdG2S8nnzBXPnYyBZhI_ryiy7kf7LOTXK9hLp0v_DNW-SCS2vkclH8clUj1_qVYuy8RrYR9Rai0beJa-e8EmrTmPbWNxIpwGt6gE46ozDIJ-QVzSjyIFcUd5OhNT3MFvCiLu-4ny1H4xHM4PvXb-2y1O-CYqC0yKJPT-6Q487zdwfdelkPoh61_KBZ11EQqSBEhfimb60UtqVsoFzItR-7mLFEJFLHgYaUNRQxd1ryWAeJcJGKo4jxHbKVTlK3S2gSxL5OrORhJEVsAeYqBn6ZQHTCo-jII2r9z5uoFEvHmh1jcyppAvsatC-W8tQmt69ZesSvek4LwZBz9NkF5zL2BOK6OX7L8DQZMm8NuaFHnuYeV40FxkUunpLm_eCFGXT1UZ8pYXyP7OQuWTUUCCZhUh7ZW_uoKePT3HDZgjwd0LRHHldPIbDgaZFN3SSbGx9gjIQ3ZTA0_UMbxTnedGbSI3cLp_85ZywvzLgGS24sh6oB6ppvPklHH3J9cxZoPO_1CKsWzl-YUuXL4twdzLPeYR9_3vvnno_IlaN2x7zuDV7tke2CXoLbdPfJ1mKWuQeAWhfhwzwa_QCQhIDS |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB6VVIhy4BFauhSQkRC3RNm1vd49hpaSIiWNBBHhZHlfJSJsqiQrEk78BH4jv4SZfdGoRQrcIq3HyU7G4288n2cAXiZcBbFtRAv3LoEBCpqxoRMxbpQbck_wwKb7zv2B2xuJd2M53oGqM93V9H1JuJEC413hdMrakuhPO20EjbuuRPDdgN3RYNj9VIBct4U-eZxXSC2FNrk7N061sSHdSswMYSppeFUxFG_CntcplHey9NKsv5npdBPm5vvU6X0YVrd9CnrKl3a2DNrh9-vFH7dVwQO4V2JW1i2M7CHsxGkTbhddLNdNuNuvS78umrBH8LWo_vwI4pOcIMJMGrGz6mohQ5zMjsna5gwn-UoEoTkjQuOa0bEwjmbn2RKXQpwLdrPVZDox8_WvHz9Pyp69S0YezxAdPr3Yh9Hpmw_HvVbZ2KEVurbXafmhFyovoFLvHdsYKYyrjKcwrvftKI4cJxGJ9CPPx9gzEBGPfckj30tEHKooDB1-AI10lsaHwBIvsv3ESB6EUkQG8apy0MASdDOUUw4tUNW_q8Oy6jk135jqK9EP6leTfqknp69z_eqVBXYteVlU_thC5hANSJsLdNB69N6htDCG0D4GeRa8yq2qnguVS6Q6JfXHwVs96PnDvqOEti04yM2uHigIFeJLWXBU2aEuHc1Cc-liwI2w2IIX9VP0EJT2MWk8yxbaRjwi8Zc6ODX7yxjFOV1ZdqQFjwvD_vPO1CfY4T5qcsPk6wFUoHzzSTr5nBcqx2CeErcWOPXi-AdVqnwVbS2gX5-d9-njk__5uiPYK3ghdL72FBrLeRY_Q7i5DJ6XLuY36oJosg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Design+and+Inference+for+Cancer+Biomarker+Study+with+an+Outcome+and+Auxiliary-Dependent+Subsampling&rft.jtitle=Biometrics&rft.au=Wang%2C+Xiaofei&rft.au=Zhou%2C+Haibo&rft.date=2010-06-01&rft.pub=Blackwell+Publishing+Inc&rft.issn=0006-341X&rft.eissn=1541-0420&rft.volume=66&rft.issue=2&rft.spage=502&rft.epage=511&rft_id=info:doi/10.1111%2Fj.1541-0420.2009.01280.x&rft.externalDocID=US201301849642 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-341X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-341X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-341X&client=summon |